Isorhamnetin Alleviates Steatosis and Fibrosis in Mice with Nonalcoholic Steatohepatitis

Nonalcoholic steatohepatitis (NASH) is the most severe and progressive form of nonalcoholic fatty liver disease (NAFLD), which can lead to life-threatening conditions, however, there is still no approved drug for the treatment of NASH. In this study we used human-like NASH mouse model and treated or...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Sci Rep
Hauptverfasser: Ganbold, Munkhzul, Owada, Yohei, Ozawa, Yusuke, Shimamoto, Yasuhiro, Ferdousi, Farhana, Tominaga, Kenichi, Zheng, Yun-Wen, Ohkohchi, Nobuhiro, Isoda, Hiroko
Format: Artigo
Sprache:Inglês
Veröffentlicht: Nature Publishing Group UK 2019
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6838085/
https://ncbi.nlm.nih.gov/pubmed/31700054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-52736-y
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge